Is Terazosin registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Terazosin.

Is Terazosin approved by the US FDA?

Drugs@FDA lists 16 application product lines for Terazosin, including TERAZOSIN HYDROCHLORIDE (Prescription); TERAZOSIN HYDROCHLORIDE (Prescription); TERAZOSIN HYDROCHLORIDE (Prescription); TERAZOSIN HYDROCHLORIDE (Prescription); TERAZOSIN HYDROCHLORIDE (Prescription).

Active substance

Terazosin

SFDA 2
US FDA 16
Health Canada 8
US price lines 4
NHS prices 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ITRIN 2MG TAB	2 mg	Tablet · Oral use	30 Blister	SAR 39.75	NCE · Prescription	ABBVIE SRL	Withdrawn by MAH · Not Marketed
ITRIN 5MG TAB	5 mg	Tablet · Oral use	14 Blister	SAR 54.55	NCE · Prescription	Abbott Laboratories	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	capsule · oral	SENORES PHARMS	Prescription	30 Mar 1998
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	capsule · oral	BIONPHARMA	Prescription	28 Jul 2000
TERAZOSIN HYDROCHLORIDE	EQ 2MG BASE; EQ 1MG BASE; EQ 5MG BASE; EQ 10MG BASE	capsule · oral	HERITAGE PHARMA AVET	Prescription	30 Jan 2001
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	capsule · oral	JUBILANT CADISTA	Prescription	20 Dec 2004
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	capsule · oral	AJANTA PHARMA LTD	Prescription	12 May 2025
HYTRIN	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	tablet · oral	ABBOTT	Discontinued	7 Aug 1987
HYTRIN	EQ 1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons; EQ 2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons; EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons; EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	capsule · oral	ABBOTT	Discontinued	14 Dec 1994
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	tablet · oral	SANDOZ	Discontinued	31 Dec 1998
TERAZOSIN HYDROCHLORIDE	EQ 5MG BASE; EQ 1MG BASE; EQ 2MG BASE; EQ 10MG BASE	capsule · oral	PHARMOBEDIENT	Discontinued	11 Feb 2000
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	tablet · oral	IVAX SUB TEVA PHARMS	Discontinued	21 Apr 2000
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	tablet · oral	CHARTWELL RX	Discontinued	28 Apr 2000
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	tablet · oral	TEVA	Discontinued	18 May 2000
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	capsule · oral	PHARMOBEDIENT	Discontinued	1 Dec 2000
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	capsule · oral	HIKMA PHARMS	Discontinued	12 Apr 2001
TERAZOSIN HYDROCHLORIDE	EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE; EQ 10MG BASE	capsule · oral	RANBAXY LABS LTD	Discontinued	22 Aug 2002
TEZRULY	EQ 1MG BASE/ML	solution · oral	NOVITIUM PHARMA	Discontinued	29 Jul 2024

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
APO-TERAZOSIN	02234502	1 MG	TABLET · ORAL	APOTEX INC
APO-TERAZOSIN	02234503	2 MG	TABLET · ORAL	APOTEX INC
APO-TERAZOSIN	02234504	5 MG	TABLET · ORAL	APOTEX INC
APO-TERAZOSIN	02234505	10 MG	TABLET · ORAL	APOTEX INC
PMS-TERAZOSIN	02243518	1 MG	TABLET · ORAL	PHARMASCIENCE INC
PMS-TERAZOSIN	02243519	2 MG	TABLET · ORAL	PHARMASCIENCE INC
PMS-TERAZOSIN	02243520	5 MG	TABLET · ORAL	PHARMASCIENCE INC
PMS-TERAZOSIN	02243521	10 MG	TABLET · ORAL	PHARMASCIENCE INC

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
US NADAC	TERAZOSIN 1 MG CAPSULE	$0.10823	per EA	23 Sep 2026
US NADAC	TERAZOSIN 10 MG CAPSULE	$0.13049	per EA	23 Sep 2026
US NADAC	TERAZOSIN 2 MG CAPSULE	$0.10551	per EA	23 Sep 2026
US NADAC	TERAZOSIN 5 MG CAPSULE	$0.10819	per EA	23 Sep 2026
NHS Drug Tariff	Terazosin 10mg tablets	£8.89	28 tablet	1 Oct 2026
NHS Drug Tariff	Terazosin 2mg tablets	£2.65	28 tablet	1 Oct 2026
NHS Drug Tariff	Terazosin 5mg tablets	£3.60	28 tablet	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.